Chindia Alert: You’ll be Living in their World Very Soon
aims to alert you to the threats and opportunities that China and India present. China and India require serious attention; case of ‘hidden dragon and crouching tiger’.
Without this attention, governments, businesses and, indeed, individuals may find themselves at a great disadvantage sooner rather than later.
The POSTs (front webpages) are mainly 'cuttings' from reliable sources, updated continuously.
The PAGEs (see Tabs, above) attempt to make the information more meaningful by putting some structure to the information we have researched and assembled since 2006.
Six animals inoculated with vaccine candidate then exposed to virus did not catch Covid-19 after 28 days
Up to 60 million doses could be produced by Serum Institute of India this year
Microbiologist Elisa Granato gets an injection on Thursday as part of the first human trials in Britain for a potential coronavirus vaccine. Photo: University of Oxford via AP
A leading candidate for a Covid-19 vaccine has shown promising results in animal trials, and is expected to see mass production in India within months.
The Serum Institute of India, the world’s largest maker of vaccines by volume, said on Tuesday that it plans this year to produce up to 60 million doses of a potential vaccine developed by the University of Oxford, which is under clinical trial in Britain.
While the vaccine candidate, called “ChAdOx1 nCoV-19”, is yet to be proven to work against Covid-19, Serum decided to start manufacturing it as it had shown success in animal trials and had progressed to tests on humans, Serum Chief Executive Adar Poonawalla said.
Six rhesus macaque monkeys were inoculated with the vaccine candidate at the National Institutes of Health’s Rocky Mountain Laboratory in Montana last month, according to The New York Times.
Covid-19 vaccine trial starts in Oxford, but remdesivir treatment reportedly flops in China tests
The subjects were exposed afterwards to large quantities of the novel coronavirus, but all six remained healthy after more than 28 days, the newspaper reported, citing researcher Vincent Munster, who conducted the test.
More than 3 million people have been reported to be infected globally and over 210,000 have died from Covid-19, the respiratory disease caused by the coronavirus.
“They are a bunch of very qualified, great scientists [at Oxford] … That’s why we said we will go with this and that’s why we are confident,” Poonawalla told Reuters in a phone interview.
“Being a private limited company, not accountable to public investors or bankers, I can take a little risk and sideline some of the other commercial products and projects that I had planned in my existing facility,” Poonawalla said.
Bill Gates hopes his virus vaccine ‘manufacturing within a year’
27 Apr 2020
As many as 100 potential Covid-19 candidate vaccines are now under development by biotech and research teams around the world, and at least five of these are in preliminary testing in people in what are known as phase one clinical trials.
Poonawalla said he hoped trials of the Oxford vaccine, due to finish in about September, would be successful. Oxford scientists said last week the main focus of initial tests was to ascertain not only whether the vaccine worked but that it induced good immune responses and no unacceptable side effects.
Serum, owned by the Indian billionaire Cyrus Poonawalla, plans to make the vaccine at its two manufacturing plants in the western city of Pune, aiming to produce up to 400 million doses next year if all goes well, Poonawalla said.
“A majority of the vaccine, at least initially, would have to go to our countrymen before it goes abroad,” he said, adding that Serum would leave it to the Indian government to decide which countries would get how much of the vaccine and when.
Rhesus macaque monkeys are often used in animal testing because of their similarity to humans. Photo: AFP
Serum envisages a price of 1,000 rupees (US$14.70) per vaccine, but governments would give it to people without charge, he said.
He said Prime Minister Narendra Modi’s office was “very closely” involved in the vaccine production and the company is hoping the government will help foot the cost of making it.
Over roughly the next five months, Serum will spend some 300 million to 400 million rupees (US$4.4 million to US$5.9 million) on making around 3-5 million doses per month, he said. “[The government] are very happy to share some risk and fund something with us, but we haven’t really pencilled anything down yet,” Poonawalla said.
Coronavirus: clinical trial begins on third vaccine candidate in China
22 Apr 2020
Serum has also partnered with the US biotech firm Codagenix and Austria’s Themis on two other Covid-19 vaccine candidates and plans to announce a fourth alliance in a couple of weeks, he said.
Serum’s board last week also agreed to invest roughly 6 billion rupees (US$8.8 billion) on making a new manufacturing unit to solely produce coronavirus vaccines, Poonawalla said.
KATHMANDU, April 19 (Xinhua) — A German scholar has recently found that the right to education for Uygurs and people of other ethnic groups is well protected in China’s Xinjiang region, as young people there enjoy increasingly better opportunities.
Michael Heinrich, who has been teaching German in Minzu University of China for more than five years, said in an article published on Online Khabar news website in March that he has “paid close attention to the development of Chinese education in recent years, especially the education situation in ethnic minority areas.”
Heinrich said he has taught a Xinjiang Uygur student, who often talks with him about the education situation in her hometown and appreciates government policies on education.
The Uygur student has told Heinrich that she lives in a place where she receives Islamic religious education and China’s nine-year compulsory education, and the Uygur students in Xinjiang can enjoy preferential policies, such as extra points in college entrance examination, special policies for college admissions, and employment policy support.
In recent years, the Chinese government has intensified policy support on education in Xinjiang Uygur Autonomous Region, and increased investment in educational resources, especially those on vocational education, the article read.
“Through vocational education, more Uyghur Muslim students can enhance their survival skills and work harder by themselves and improve their living standards with these hands,” it said.
For some time, Xinjiang has been plagued by terrorism, religious extremism and separatism, according to the passage, and carrying out vocational education and training in Xinjiang is an effective measure to promote the rule of law and a practical action to protect the vital interests of people of all ethnic groups there.
It is also a just move in fighting extremism and terrorism to contribute to the stability in Xinjiang, it added.
Some Western media outlets as well as some U.S. politicians often slander the Chinese government under the guise of “human rights,” which does not only disregard the facts but also interferes with China’s sovereignty, Heinrich pointed out.
The situation in Xinjiang that they saw was completely different from the stories told by some Western politicians and media, Heinrich quoted some people who have visited Xinjiang and witnessed its development as saying.
The rights to life and development of people of all ethnic groups in Xinjiang are protected to the largest extent, Heinrich added.
CHINDIA ALERT: You'll be living in their world, very soon 